Results 71 to 80 of about 6,090,817 (193)

International Symposium for Thyroid Eye Disease (June 2016, London)

Клиническая и экспериментальная тиреоидология, 2017
In June 2016, an International Symposium dedicated to the cutting edge research and achievements in Thyroid Eye Disease (TED) diagnosis and treatment was held in London. The symposium was organized by the International Thyroid Eye Disease (ITEDs). It was
Natalia Y. Sviridenko, Marina S. Sheremeta, Yaroslav O. Grusha   +2 more
doaj   +1 more source

Exploring the Therapeutic Mechanism of Xiehuo Pingtu San in Treating Thyroid Eye Disease Based on Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation

International Journal of Endocrinology, Volume 2026, Issue 1, 2026.
Background Xiehuo Pingtu San (XHPTS) has been shown to be safe and effective in treating thyroid eye disease (TED), yet its underlying mechanisms remain unclear. This study aimed to elucidate the active ingredients of XHPTS and their therapeutic mechanisms in TED through network pharmacology, molecular docking, and molecular dynamics simulations ...
Ping Wang, Ruiyan Liu, Xin Shang, Yu Fu, Ying Wang, Shuxun Yan, Suraiya Saleem   +6 more
wiley   +1 more source

Objective Markers for Thyroid Eye Disease (TED) Activity, Severity 387 and Progression

, 2010
Thyroid eye disease (TED) also called Graves\u27 ophthalmopathy, can result in visual disability, including blurred or double vision, visual loss), discomfort, and facial ...
Kimberly P. Cockerham, MD, FACS
core  

Early Low‐Dose Rituximab for Mild‐to‐Moderate Thyroid Eye Disease: A Preliminary Evaluation of Efficacy and Safety

International Journal of Endocrinology, Volume 2026, Issue 1, 2026.
Background Thyroid eye disease (TED) is an autoimmune inflammatory condition linked to thyroid dysfunction, which can result in disfigurement and potential vision loss. Recently, immunomodulatory therapies such as rituximab have demonstrated potential benefit in managing TED.
Ming Lu, Luqiang Wang, Xuelian Zhang, Suraiya Saleem   +3 more
wiley   +1 more source

Exploring the Potential Roles of Oxidative Stress–Related Genes in Thyroid Eye Disease and Graves’ Disease

Journal of Ophthalmology, Volume 2026, Issue 1, 2026.
Purpose To reveal the significance of oxidative stress–related genes in the pathogenesis of thyroid eye disease (TED) and Graves’ disease (GD) using a bioinformatics approach. Methods Utilizing datasets from the GEO database, we used the “limma” package to detect differentially expressed genes (DEGs). Oxidative stress–related DEGs related to TED and GD
Weili Zhang, Qinying Huang, Jinying Li, Srijoni Sengupta   +3 more
wiley   +1 more source

Thyroid Eye Disease - Pilot Study

, 2013
Thyroid eye disease (TED) is a poorly understood and difficult disease process to manage. The ultimate goal of TED research is to be able to perform clinical efficacy studies of therapeutic strategies for active TED.
Nicholas E. Frisard; Anne P. Rowland; Marie D. Acierno; Kimberly P. Cockerham; Adham Al Hariri
core  

Comparison Between Oculoplastic Surgeons and Two Large Language Models in the Nonsurgical Management of Thyroid Eye Disease: A Questionnaire‐Based Cross‐Sectional Study

Scientifica, Volume 2026, Issue 1, 2026.
Background Thyroid eye disease (TED) presents heterogeneous clinical manifestations requiring nuanced, individualized management. Large language models (LLMs) have shown potential in clinical reasoning, but their consistency with physician decision‐making in nonsurgical TED management remains unclear. Methods A structured 19‐item questionnaire covering
Shiqi Hui, Lihua Luo, Zhijia Hou, Dongmei Li, Anjali Chauhan   +4 more
wiley   +1 more source

Pegvisomant in severe, treatment-resistant thyroid eye disease: a case report

Drugs in Context
Teprotumumab, a monoclonal antibody against the IGF1 receptor, has proven effective in the treatment of thyroid eye disease (TED). Pegvisomant reduces IGF1 levels through selective inhibition of growth hormone receptors.
Laura Köröskényi, Noémi Szkibák, Zita Steiber, Sándor Barna, Edit B Nagy, Zsolt Karányi, József Balla, Miklós Bodor, Endre V Nagy, Annamária Erdei   +9 more
doaj   +1 more source

Immune checkpoints: new insights into the pathogenesis of thyroid eye disease

Frontiers in Immunology
Thyroid eye disease (TED) is a disfiguring autoimmune disease characterized by changes in the orbital tissues and is caused by abnormal thyroid function or thyroid-related antibodies. It is the ocular manifestation of Graves’ disease.
Xingyi Shu, Yuchao Shao, Yuqing Chen, Chengcheng Zeng, Xiao Huang, Ruili Wei   +5 more
doaj   +1 more source

Ocular Motility in Thyroid Eye Disease Evaluation and Surgery

, 2010
Evaluation of diplopia in the patient with Thyroid Eye Disease requires differentiating between monocular and binocular diplopia, both of which may occur.curriculum_fellow; IC-E4di-thyroid ...
Steven E. Feldon, MD, MBA
core